Long-term follow-up of cancer patients treated with gene therapy medicinal products

European Union requirements are discussed for the long-term follow-up of advanced therapy medicinal products, as well as how they can be applied to cancer patients treated with gene therapy medicinal products in the context of clinical trials, as described in a specific guideline issued by Gene Therapy Working Party at the European Medicine Agency. Copyright © 2012 John Wiley & Sons, Ltd.